Publications by authors named "Abizaid A"

Introduction: The long-term efficacy of renal denervation (RDN) has not been extensively documented.

Aim: To describe the long-term follow-up of patients after RDN.

Methods: We evaluated patients with resistant hypertension (RH) who underwent RDN with irrigated catheter from 2012 to 2014 at a single centre.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of a new implant called the DynamX bioadaptor compared to a traditional drug-eluting stent (DES) in improving outcomes for patients undergoing percutaneous coronary intervention (PCI) due to heart disease.
  • Conducted across 20 hospitals in Sweden, the study randomly assigned eligible patients aged 18-85 to receive either the bioadaptor or a zotarolimus-eluting DES, measuring outcomes such as target lesion failure after 12 months.
  • The primary goal is to ensure the new device is not worse than the DES by measuring specific heart-related adverse events and ensuring that the risk difference remains within a predefined limit, indicating safety and efficacy.
View Article and Find Full Text PDF

Background: Transcatheter aortic valve implantation (TAVI) is a well-established treatment for symptomatic patients with aortic stenosis. Yet, the impact of sex differences and public vs. private procedural setting on TAVI outcomes remain uncertain.

View Article and Find Full Text PDF

Aims: Cardiogenic shock (CS) and cardiac arrest (CA) are serious complications in ST-elevation myocardial infarction (STEMI) patients, with lack of long-term data according to their timing of occurrence. This study sought to determine the incidence and relationship between the timing of occurrence and prognostic impact of CS and CA complicating STEMI in the long-term follow-up.

Methods And Results: We conducted a retrospective analysis of consecutive STEMI patients treated between 2004 and 2017.

View Article and Find Full Text PDF

Background And Aims: Colchicine has demonstrated efficacy in treating coronary artery disease, but its efficacy in peripheral artery disease (PAD) remains uncertain. This study aims to address this gap in knowledge.

Methods: A retrospective cohort study was conducted using the TriNetX Network, selecting patients with lower limb PAD between January 1, 2011, and January 1, 2024.

View Article and Find Full Text PDF

Background: Cerebrovascular events remain one of the most devastating complications of transcatheter aortic valve implantation (TAVI). Data from real-world contemporary cohorts on longitudinal trends and outcomes remain limited. The aim of this study was to assess incidence, temporal trends, predictors, and outcomes of cerebrovascular events following transfemoral TAVI.

View Article and Find Full Text PDF

Background: Robust data on the learning curve (LC) of transcatheter aortic valve replacement (TAVR) are lacking in developing countries.

Objective: To assess TAVR's LC in Brazil over time.

Methods: We analyzed data from the Brazilian TAVR registry from 2008 to 2023.

View Article and Find Full Text PDF

Background: The DynamX Novolimus-Eluting Coronary Bioadaptor System ( Bioadaptor) has uncaging elements that disengage after the resorption of the polymer coating, aiming to restore vessel function in the treated segment and to avoid long-term adverse outcomes associated with the permanent caging of the coronary artery seen with conventional stenting.

Methods: This prospective, multicenter, single-arm first-in-human study enrolled 50 patients in Belgium and Italy who were treated with the DynamX Bioadaptor. Eligible patients had lesions in coronary arteries measuring between 2.

View Article and Find Full Text PDF
Article Synopsis
  • Transcatheter mitral valve-in-valve replacement is a less invasive option for high-risk patients with failed bioprosthetic mitral valves, and this study focuses on its outcomes in intermediate-risk patients.
  • A total of 50 patients, mostly around 70 years old, were treated using a balloon-expandable valve, and results showed no deaths or strokes within one year post-procedure.
  • The procedure led to significant improvement in patients' symptoms and quality of life, with most experiencing low levels of mitral regurgitation and overall better heart function after one year.
View Article and Find Full Text PDF
Article Synopsis
  • * While ghrelin normally struggles to enter the brain, social stress may make it easier to pass through the blood-brain barrier, allowing it to reach more areas in the brain that regulate feeding.
  • * In experiments with mice, those exposed to social stress showed increased ghrelin in key brain areas and changes in brain cells, suggesting that stress enhances the hormone's ability to affect the brain's reward and feeding systems.
View Article and Find Full Text PDF

Background: Oncological patients with coronary artery disease face an elevated risk of hemorrhagic and ischemic events following percutaneous coronary intervention. Despite medical guidelines recommending minimal dual antiplatelet therapy (DAPT) duration for patients with cancer, dedicated data on abbreviated DAPT in this population is lacking. This study aims to evaluate the occurrence of ischemic and hemorrhagic events in patients with cancer compared with other high-bleeding risk individuals.

View Article and Find Full Text PDF

Ghrelin, a hormone secreted by the stomach, binds to the growth hormone secretagogue receptor (GHSR) in various brain regions to produce a number of behavioral effects that include increased feeding motivation. During social defeat stress, ghrelin levels rise in correlation with increased feeding and potentially play a role in attenuating the anxiogenic effects of social defeat. One region implicated in the feeding effects of ghrelin is the ventral tegmental area (VTA), a region implicated in reward seeking behaviors, and linked to social defeat in mice.

View Article and Find Full Text PDF

Background: Quantitative flow ratio (QFR) and myocardial perfusion scintigraphy (MPS) are utilized for assessing coronary artery disease (CAD) significance. We aimed to analyze their concordance and prognostic impact.

Aims: We aimed to analyze the concordance between QFR and MPS and their risk stratification.

View Article and Find Full Text PDF
Article Synopsis
  • Major bleeding is a common complication after transcatheter aortic valve replacement (TAVR) and is linked to worse clinical outcomes, making its study crucial.
  • A comprehensive analysis of 23,562 patients showed a decrease in major bleeding incidents from 11.5% to 5.5% over a decade (2007-2022) and identified female sex and peripheral vascular disease as key predictors.
  • Patients experiencing major bleeding faced significantly higher mortality within 30 days and up to a year compared to those without major bleeding, highlighting the serious risks associated with this complication.
View Article and Find Full Text PDF

Background: Central Illustration : Percutaneous Strategies in Structural Heart Diseases: Focus on Chronic Heart Failure Transcatheter devices for monitoring and treating advanced chronic heart failure patients. PA: pulmonary artery; LA: left atrium; AFR: atrial flow regulator; TASS: Transcatheter Atrial Shunt System; VNS: vagus nerve stimulation; BAT: baroreceptor activation therapy; RDN: renal sympathetic denervation; F: approval by the American regulatory agency (FDA); E: approval by the European regulatory agency (CE Mark).

Background: Innovations in devices during the last decade contributed to enhanced diagnosis and treatment of patients with cardiac insufficiency.

View Article and Find Full Text PDF

This study aimed to evaluate the incidence and clinical implications of myocardial injury, as determined by cardiac biomarker increase, in patients who underwent mitral bioprosthesis dysfunction treatment with transcatheter mitral valve replacement (TMVR) versus surgical mitral valve replacement reoperation (SMVR-REDO). Between 2014 and 2023, 310 patients with mitral bioprosthesis failure were included (90 and 220 patients for TMVR and SMVR-REDO, respectively). Multivariable analysis and propensity score matching were performed to adjust for the intergroup differences in baseline characteristics.

View Article and Find Full Text PDF

Background: Periprocedural myocardial injury (PPMI) frequently occurs after transcatheter aortic valve implantation (TAVI), although its impact on long-term mortality is uncertain.

Methods: We performed a pooled analysis of Kaplan-Meier-derived individual patient data to compare survival in patients with and without PPMI after TAVI. Flexible parametric models with B-splines and landmark analyses were used to determine PPMI prognostic value.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of mitral valve-in-valve (ViV) procedures on patient outcomes, particularly focusing on device position and asymmetry.
  • Researchers analyzed data from 222 patients in the VIVID Registry and found that residual mitral valve stenosis was common, affecting 50% of participants, whereas left ventricular outflow tract (LVOT) obstruction was rare, occurring in 3.2% of cases.
  • Key findings included that greater asymmetry of the transcatheter heart valve was linked to higher rates of residual stenosis, while deeper atrial implantation seemed to reduce the likelihood of LVOT obstruction.
View Article and Find Full Text PDF

B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro BNP) are cardiac biomarkers that are released in response to increased ventricular and atrial wall stress. Aortic stenosis (AS) leads to hemodynamic changes and left ventricular hypertrophy and may be associated with natriuretic peptide levels. Several studies have shown that increased natriuretic peptide levels are correlated with AS severity and can predict the need for intervention.

View Article and Find Full Text PDF